GILEAD SCIENCES, INC. — Director's Dealing 2018

Feb 21, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2018-02-20

Reporting Person: Alton Gregg H (EVP,Corporate &Medical Affairs)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-20	Common Stock	S	14435	$81.5374	Disposed	0	Indirect

Footnotes

F1: Open Market Sale of Family Trust Shares

F2: Sale prices reported for the transactions reported here range from $81.4601 to $81.60. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.